ScholarIQanswers from OpenAlex & ORCID
Vikas Gupta
ResearcherPublications, citations & collaboration network
Vikas Gupta is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Vikas Gupta have?
ScholarIQindexed works
Vikas Gupta has 893 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Vikas Gupta have?
ScholarIQcitation count
Vikas Gupta has 25,539 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Vikas Gupta?
ScholarIQh-index
Vikas Gupta has an h-index of 76 in OpenAlex.
What is the i10-index of Vikas Gupta?
ScholarIQi10-index
Vikas Gupta has an i10-index of 328 in OpenAlex.
What is the ORCID of Vikas Gupta?
ScholarIQorcid
The ORCID for Vikas Gupta is on the source record.
What is the OpenAlex record for Vikas Gupta?
ScholarIQopenalex
The OpenAlex for Vikas Gupta is on the source record.
What are the most-cited papers on Vikas Gupta?
ScholarIQmost cited works
Risk factors for acute GVHD and survival after hematopoietic cell transplantation
Madan Jagasia, Mukta Arora, Mary E.D. Flowers, Nelson J. Chao, Philip L. McCarthy, Corey Cutler, Álvaro Urbano-Ispizúa, Steven Z. Pavletic, Michael Haagenson, Mei-Jie Zhang, Joseph H. Antin, Brian J. Bolwell, Christopher Bredeson, Jean‐Yves Cahn, Mitchell S. Cairo, Robert Peter Gale, Vikas Gupta, Stephanie J. Lee, Mark R. Litzow, Daniel J. Weisdorf, Mary M. Horowitz, Theresa Hahn
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I
Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, R. S. Levy, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, E. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Azra Raza, Kris Vaddi, William Sun, Wei Peng, V. Sandor, Hagop M. Kantarjian, For the COMFORT-I investigators
Outcome of Transplantation for Myelofibrosis
Karen K. Ballen, Smriti Shrestha, Kathleen A. Sobocinski, Mei-Jie Zhang, Asad Bashey, Brian J. Bolwell, Francisco Cervantes, Steven M. Devine, Robert Peter Gale, Vikas Gupta, Theresa Hahn, William J. Hogan, Nicolaus Kröger, Mark R. Litzow, David I. Marks, Richard T. Maziarz, Philip L. McCarthy, Gary J. Schiller, Harry C. Schouten, Vivek Roy, Peter H. Wiernik, Mary M. Horowitz, Sergio Giralt, Mukta Arora
A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis
Alessandro M. Vannucchi, H. Kantarjian, Jean‐Jacques Kiladjian, Jason Gotlib, F. Cervantes, Ruben A. Mesa, Nicholas J. Sarlis, Wei Peng, V. Sandor, P. Gopalakrishna, Abdel Hmissi, Viktoriya Stalbovskaya, Vikas Gupta, Claire Harrison, Srđan Verstovšek, on behalf of the COMFORT Investigators